These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 7720520

  • 1. Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
    Newton DJ, Wang RW, Lu AY.
    Drug Metab Dispos; 1995 Jan; 23(1):154-8. PubMed ID: 7720520
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA, Tjia JF, Back DJ.
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [Abstract] [Full Text] [Related]

  • 5. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
    Yamazaki H, Guo Z, Persmark M, Mimura M, Inoue K, Guengerich FP, Shimada T.
    Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
    [Abstract] [Full Text] [Related]

  • 6. Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs.
    Li J, Liu Y, Zhang JW, Wei H, Yang L.
    Comp Med; 2006 Aug; 56(4):286-90. PubMed ID: 16941956
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of glyburide on human cytochrome p450 isoforms in human liver microsomes.
    Kim KA, Park JY.
    Drug Metab Dispos; 2003 Sep; 31(9):1090-2. PubMed ID: 12920163
    [Abstract] [Full Text] [Related]

  • 8. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
    Tassaneeyakul W, Birkett DJ, Veronese ME, McManus ME, Tukey RH, Quattrochi LC, Gelboin HV, Miners JO.
    J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
    [Abstract] [Full Text] [Related]

  • 9. Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes.
    Ono S, Hatanaka T, Hotta H, Satoh T, Gonzalez FJ, Tsutsui M.
    Xenobiotica; 1996 Jul; 26(7):681-93. PubMed ID: 8819299
    [Abstract] [Full Text] [Related]

  • 10. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ, Yokoyama H, Chiba K, Wanwimolruk S, Ishizaki T.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
    [Abstract] [Full Text] [Related]

  • 11. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity.
    Pearce RE, McIntyre CJ, Madan A, Sanzgiri U, Draper AJ, Bullock PL, Cook DC, Burton LA, Latham J, Nevins C, Parkinson A.
    Arch Biochem Biophys; 1996 Jul 15; 331(2):145-69. PubMed ID: 8660694
    [Abstract] [Full Text] [Related]

  • 12. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
    Gallagher EP, Wienkers LC, Stapleton PL, Kunze KL, Eaton DL.
    Cancer Res; 1994 Jan 01; 54(1):101-8. PubMed ID: 8261428
    [Abstract] [Full Text] [Related]

  • 13. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
    Kasahara M, Suzuki H, Komiya I.
    Drug Metab Dispos; 2000 Apr 01; 28(4):409-17. PubMed ID: 10725309
    [Abstract] [Full Text] [Related]

  • 14. Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.
    Lee KS, Kim SK.
    J Appl Toxicol; 2013 Feb 01; 33(2):100-8. PubMed ID: 21915887
    [Abstract] [Full Text] [Related]

  • 15. In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse.
    Chauret N, Gauthier A, Martin J, Nicoll-Griffith DA.
    Drug Metab Dispos; 1997 Oct 01; 25(10):1130-6. PubMed ID: 9321515
    [Abstract] [Full Text] [Related]

  • 16. Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2.
    Yoshimoto K, Echizen H, Chiba K, Tani M, Ishizaki T.
    Br J Clin Pharmacol; 1995 Apr 01; 39(4):421-31. PubMed ID: 7640150
    [Abstract] [Full Text] [Related]

  • 17. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T, Shiraga T, Mitani Y, Terakawa M, Tokuma Y, Kagayama A.
    Drug Metab Dispos; 2000 Sep 01; 28(9):1128-34. PubMed ID: 10950860
    [Abstract] [Full Text] [Related]

  • 18. Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver.
    Jönsson G, Aström A, Andersson P.
    Drug Metab Dispos; 1995 Jan 01; 23(1):137-42. PubMed ID: 7720517
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.